BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23283758)

  • 1. Differential Response to Methylphenidate in Inattentive and Combined Subtype ADHD.
    Beery SH; Quay HC; Pelham WE
    J Atten Disord; 2017 Jan; 21(1):62-70. PubMed ID: 23283758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial.
    Hadar Y; Hocherman S; Lamm O; Tirosh E
    Child Psychiatry Hum Dev; 2021 Feb; 52(1):96-103. PubMed ID: 32342235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of methylphenidate on sustained attention among adolescents with attention-deficit hyperactivity disorder.
    Lufi D; Bassin-Savion S; Rubel L
    Neurocase; 2015; 21(6):802-8. PubMed ID: 25771849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.
    Cox DJ; Humphrey JW; Merkel RL; Penberthy JK; Kovatchev B
    J Am Board Fam Pract; 2004; 17(4):235-9. PubMed ID: 15243010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).
    DeVito EE; Blackwell AD; Clark L; Kent L; Dezsery AM; Turner DC; Aitken MR; Sahakian BJ
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):531-9. PubMed ID: 18818905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder.
    Günther T; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):179-86. PubMed ID: 20578930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology.
    Cubero-Millán I; Ruiz-Ramos MJ; Molina-Carballo A; Martínez-Serrano S; Fernández-López L; Machado-Casas I; Tortosa-Pinto P; Ruiz-López A; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
    Psychopharmacology (Berl); 2017 Jan; 234(2):267-279. PubMed ID: 27807606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG; Kolko DJ
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI
    Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
    Su Y; Yang L; Stein MA; Cao Q; Wang Y
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methylphenidate on impulsive responding in children with attention-deficit hyperactivity disorder.
    Malone MA; Swanson JM
    J Child Neurol; 1993 Apr; 8(2):157-63. PubMed ID: 8505479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.